Global Biologics and Biosimilars Market Research Report 2016

Global Biologics and Biosimilars Market Research Report 2016

1 Biologics and Biosimilars Market Overview

1.1 Product Overview and Scope of Biologics and Biosimilars

1.2 Biologics and Biosimilars Segment by Type

1.2.1 Global Production Market Share of Biologics and Biosimilars by Type in 2015

1.2.2 Biologics

1.2.3 Biosimilars

1.2.4 Type III

1.3 Biologics and Biosimilars Segment by Application

1.3.1 Biologics and Biosimilars Consumption Market Share by Application in 2015

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Others

1.4 Biologics and Biosimilars Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Biologics and Biosimilars (2011-2021)

2 Global Biologics and Biosimilars Market Competition by Manufacturers

2.1 Global Biologics and Biosimilars Production and Share by Manufacturers (2015 and 2016)

2.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Biologics and Biosimilars Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Sales Area and Product Type

2.5 Biologics and Biosimilars Market Competitive Situation and Trends

2.5.1 Biologics and Biosimilars Market Concentration Rate

2.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Biologics and Biosimilars Production, Revenue (Value) by Region (2011-2016)

3.1 Global Biologics and Biosimilars Production and Market Share by Region (2011-2016)

3.2 Global Biologics and Biosimilars Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Biologics and Biosimilars Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Biologics and Biosimilars Consumption by Regions (2011-2016)

4.2 North America Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Biologics and Biosimilars Production, Revenue (Value), Price Trend by Type

5.1 Global Biologics and Biosimilars Production and Market Share by Type (2011-2016)

5.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2011-2016)

5.3 Global Biologics and Biosimilars Price by Type (2011-2016)

5.4 Global Biologics and Biosimilars Production Growth by Type (2011-2016)

6 Global Biologics and Biosimilars Market Analysis by Application

6.1 Global Biologics and Biosimilars Consumption and Market Share by Application (2011-2016)

6.2 Global Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Biologics and Biosimilars Manufacturers Profiles/Analysis

7.1 Pfizer

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Biologics and Biosimilars Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Pfizer Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Roche

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Biologics and Biosimilars Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Roche Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Amgen

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Biologics and Biosimilars Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Amgen Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 AbbVie

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Biologics and Biosimilars Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 AbbVie Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Sanofi

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Biologics and Biosimilars Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Sanofi Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Johnson & Johnson

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Biologics and Biosimilars Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Johnson & Johnson Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Novo Nordisk

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Biologics and Biosimilars Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Novo Nordisk Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Novartis

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Biologics and Biosimilars Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Novartis Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

8 Biologics and Biosimilars Manufacturing Cost Analysis

8.1 Biologics and Biosimilars Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Biologics and Biosimilars

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Biologics and Biosimilars Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Biologics and Biosimilars Market Forecast (2016-2021)

12.1 Global Biologics and Biosimilars Production, Revenue Forecast (2016-2021)

12.2 Global Biologics and Biosimilars Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Biologics and Biosimilars Production Forecast by Type (2016-2021)

12.4 Global Biologics and Biosimilars Consumption Forecast by Application (2016-2021)

12.5 Biologics and Biosimilars Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Biologics and Biosimilars

Figure Global Production Market Share of Biologics and Biosimilars by Type in 2015

Figure Product Picture of Biologics

Table Major Manufacturers of Biologics

Figure Product Picture of Biosimilars

Table Major Manufacturers of Biosimilars

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table Biologics and Biosimilars Consumption Market Share by Application in 2015

Figure Tumor Examples

Figure Diabetes Examples

Figure Cardiovascular Examples

Figure Others Examples

Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Biologics and Biosimilars Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Biologics and Biosimilars Production of Key Manufacturers (2015 and 2016)

Table Global Biologics and Biosimilars Production Share by Manufacturers (2015 and 2016)

Figure 2015 Biologics and Biosimilars Production Share by Manufacturers

Figure 2016 Biologics and Biosimilars Production Share by Manufacturers

Table Global Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Biologics and Biosimilars Revenue Share by Manufacturers

Table 2016 Global Biologics and Biosimilars Revenue Share by Manufacturers

Table Global Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015

Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area

Table Manufacturers Biologics and Biosimilars Product Type

Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers

Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers

Table Global Biologics and Biosimilars Production by Regions (2011-2016)

Figure Global Biologics and Biosimilars Production and Market Share by Regions (2011-2016)

Figure Global Biologics and Biosimilars Production Market Share by Regions (2011-2016)

Figure 2015 Global Biologics and Biosimilars Production Market Share by Regions

Table Global Biologics and Biosimilars Revenue by Regions (2011-2016)

Table Global Biologics and Biosimilars Revenue Market Share by Regions (2011-2016)

Table 2015 Global Biologics and Biosimilars Revenue Market Share by Regions

Table Global Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Table China Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Table India Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Biologics and Biosimilars Consumption Market by Regions (2011-2016)

Table Global Biologics and Biosimilars Consumption Market Share by Regions (2011-2016)

Figure Global Biologics and Biosimilars Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Biologics and Biosimilars Consumption Market Share by Regions

Table North America Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)

Table Europe Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)

Table China Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)

Table Japan Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)

Table India Biologics and Biosimilars Production, Consumption, Import & Export (2011-2016)

Table Global Biologics and Biosimilars Production by Type (2011-2016)

Table Global Biologics and Biosimilars Production Share by Type (2011-2016)

Figure Production Market Share of Biologics and Biosimilars by Type (2011-2016)

Figure 2015 Production Market Share of Biologics and Biosimilars by Type

Table Global Biologics and Biosimilars Revenue by Type (2011-2016)

Table Global Biologics and Biosimilars Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Biologics and Biosimilars by Type (2011-2016)

Figure 2015 Revenue Market Share of Biologics and Biosimilars by Type

Table Global Biologics and Biosimilars Price by Type (2011-2016)

Figure Global Biologics and Biosimilars Production Growth by Type (2011-2016)

Table Global Biologics and Biosimilars Consumption by Application (2011-2016)

Table Global Biologics and Biosimilars Consumption Market Share by Application (2011-2016)

Figure Global Biologics and Biosimilars Consumption Market Share by Application in 2015

Table Global Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)

Figure Global Biologics and Biosimilars Consumption Growth Rate by Application (2011-2016)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Biologics and Biosimilars Market Share (2011-2016)

Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Roche Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Figure Roche Biologics and Biosimilars Market Share (2011-2016)

Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amgen Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Biologics and Biosimilars Market Share (2011-2016)

Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AbbVie Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Figure AbbVie Biologics and Biosimilars Market Share (2011-2016)

Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Sanofi Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi Biologics and Biosimilars Market Share (2011-2016)

Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Johnson & Johnson Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Figure Johnson & Johnson Biologics and Biosimilars Market Share (2011-2016)

Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novo Nordisk Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novo Nordisk Biologics and Biosimilars Market Share (2011-2016)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Biologics and Biosimilars Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Biologics and Biosimilars

Figure Manufacturing Process Analysis of Biologics and Biosimilars

Figure Biologics and Biosimilars Industrial Chain Analysis

Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015

Table Major Buyers of Biologics and Biosimilars

Table Distributors/Traders List

Figure Global Biologics and Biosimilars Production and Growth Rate Forecast (2016-2021)

Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2016-2021)

Table Global Biologics and Biosimilars Production Forecast by Regions (2016-2021)

Table Global Biologics and Biosimilars Consumption Forecast by Regions (2016-2021)

Table Global Biologics and Biosimilars Production Forecast by Type (2016-2021)

Table Global Biologics and Biosimilars Consumption Forecast by Application (2016-2021)